Plus   Neg

Eligo, GSK Sign Deal To Advance Eligobiotics For Treatment/prevention Of Acne Vulgaris

Eligo Bioscience SA has reached a research and option agreement with GlaxoSmithKline (GSK) aimed at advancing Eligobiotics for the treatment or prevention of acne vulgaris with a pioneering CRISPR-based therapeutic for strain-specific microbiome modulation, Eligo said in a statement.

As per the terms of the deal, Eligo will receive an upfront payment and R&D funding to advance EB005, its discovery program in acne, until preclinical proof of concept.

If GSK exercises its option, GSK and Eligo will reach a license and collaboration agreement to jointly continue the development of EB005 in acne.

Eligo would be eligible to receive up to a total of $224 million in license fees and potential milestone payments, as well as royalties on global sales.

The EB005 program is applying Eligo's Eligobiotics technology to precisely modify the composition of the skin's microbiome to treat or reduce the risk of developing moderate to severe acne. Acne is a chronic inflammatory disorder.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Johnson & Johnson's single-shot COVID-19 vaccine is safe and effective as per the trial data submitted for Emergency Use Authorization, the US Food and Drug Administration said. The vaccine, known as Ad26.COV2.S, was found to prevent severe disease and death from Covid. The vaccine's EUA will be decided in a vote by FDA's vaccine advisory panel on Friday. Best Buy Co., Inc. is offering paid time off as vaccine benefit to all its employees amid the ongoing vaccinations against coronavirus. The company also announced bonuses to its hourly employees as a gratitude for the resilience shown by them as frontline workers during the crisis. The electronics retailer said it is offering paid time off for any employee who gets a COVID-19 vaccination. Entertainment company Walt Disney Co.'s exclusive streaming service Disney+ has added more content with the addition of the Star brand which launched today on the platform across Australia, New Zealand, Canada, and Europe. Disney+ with Star also launched today in Singapore, the first market to launch with the new general entertainment brand.
Follow RTT